Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

Details for Australian Patent Application No. 2004254191 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Gijsen, Henricus Jacobus Maria; Bosmans, Jean-Paul Rene Marie Andre; Mevellec, Laurence Anne

Agent Shelston IP

Pub. Number AU-B-2004254191

PCT Pub. Number WO2005/003121

Priority PCT/EP03/50239 19.06.03 EP

Filing date 10 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 11 March 2010

International Classifications

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/003121 Priority application(s): WO2005/003121

11 March 2010 Application Accepted

  Published as AU-B-2004254191

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004254193-5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides

2004254190-Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists